My Treatment Approach: Androgen Receptor Inhibitors and the Evolving Treatment Paradigm in Castration-Sensitive Prostate Cancer - Episode 8
Final Thoughts on CSPC
Experts offer concluding remarks on castration-sensitive prostate cancer, sharing their perspectives on the evolving field and expressing their aspirations for future advancements in disease treatment.
Video content above is prompted by the following questions:
- How do you foresee the early treatment paradigm for CSPC evolving in the coming years?
- Are there other novel agents you're excited about in development?
- How will their availability impact treatment sequencing strategies?
Related Content:
